These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9811314

  • 1. Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents.
    Joseph IB, Isaacs JT.
    J Natl Cancer Inst; 1998 Nov 04; 90(21):1648-53. PubMed ID: 9811314
    [Abstract] [Full Text] [Related]

  • 2. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.
    Vukanovic J, Isaacs JT.
    Cancer Res; 1995 Apr 01; 55(7):1499-504. PubMed ID: 7533663
    [Abstract] [Full Text] [Related]

  • 3. The antiangiogenic agent linomide inhibits tumor necrosis factor-alpha secretion via inhibition of its synthesis.
    Joseph IB, Isaacs JT.
    Prostate; 1996 Sep 01; 29(3):183-90. PubMed ID: 8827087
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers.
    Vukanovic J, Hartley-Asp B, Isaacs JT.
    Prostate; 1995 May 01; 26(5):235-46. PubMed ID: 7538663
    [Abstract] [Full Text] [Related]

  • 5. Antiangiogenic effects of the quinoline-3-carboxamide linomide.
    Vukanovic J, Passaniti A, Hirata T, Traystman RJ, Hartley-Asp B, Isaacs JT.
    Cancer Res; 1993 Apr 15; 53(8):1833-7. PubMed ID: 7682157
    [Abstract] [Full Text] [Related]

  • 6. Anti-angiogenic treatment with linomide as adjuvant to surgical castration in experimental prostate cancer.
    Hartley-Asp B, Vukanovic J, Joseph IB, Strandgården K, Polacek J, Isaacs JT.
    J Urol; 1997 Sep 15; 158(3 Pt 1):902-7. PubMed ID: 9258116
    [Abstract] [Full Text] [Related]

  • 7. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
    Ichikawa T, Lamb JC, Christensson PI, Hartley-Asp B, Isaacs JT.
    Cancer Res; 1992 Jun 01; 52(11):3022-8. PubMed ID: 1591718
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
    Vukanovic J, Isaacs JT.
    Cancer Res; 1995 Aug 15; 55(16):3517-20. PubMed ID: 7543015
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of linomide on advanced prostate-seminal vesicle cancers in Lobund-Wistar rats.
    Pollard M.
    Prostate; 1998 Apr 01; 35(1):43-9. PubMed ID: 9537598
    [Abstract] [Full Text] [Related]

  • 14. Impairment of growth of Listeria monocytogenes in THP-1 macrophages by granulocyte macrophage colony-stimulating factor: release of tumor necrosis factor-alpha and nitric oxide.
    Carryn S, Van de Velde S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.
    J Infect Dis; 2004 Jun 01; 189(11):2101-9. PubMed ID: 15143479
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of angiogenesis and metastases of the Lewis-lung cell carcinoma by the quinoline-3-carboxamide, Linomide.
    Borgström P, Torres Filho IP, Hartley-Asp B.
    Anticancer Res; 1995 Jun 01; 15(3):719-28. PubMed ID: 7544090
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity.
    Ching LM, Browne WL, Tchernegovski R, Gregory T, Baguley BC, Palmer BD.
    Br J Cancer; 1998 Aug 01; 78(3):336-43. PubMed ID: 9703279
    [Abstract] [Full Text] [Related]

  • 18. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
    Isaacs JT, Pili R, Qian DZ, Dalrymple SL, Garrison JB, Kyprianou N, Björk A, Olsson A, Leanderson T.
    Prostate; 2006 Dec 01; 66(16):1768-78. PubMed ID: 16955399
    [Abstract] [Full Text] [Related]

  • 19. Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair.
    Cakarova L, Marsh LM, Wilhelm J, Mayer K, Grimminger F, Seeger W, Lohmeyer J, Herold S.
    Am J Respir Crit Care Med; 2009 Sep 15; 180(6):521-32. PubMed ID: 19590023
    [Abstract] [Full Text] [Related]

  • 20. The quinoline-3-carboxamide linomide inhibits angiogenesis in vivo.
    Borgström P, Torres Filho IP, Vajkoczy P, Strandgården K, Polaçek J, Hartley-Asp B.
    Cancer Chemother Pharmacol; 1994 Sep 15; 34(4):280-6. PubMed ID: 7518359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.